This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wilex Ag. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Klaus Koch: Innovator in Pharmaceutical Formulations
Introduction
Klaus Koch is a notable inventor based in Mering, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable dosage forms of phenylalanine derivatives. His work focuses on improving pharmaceutical formulations that can be used as urokinase inhibitors for treating malignant tumors and tumoral metastases.
Latest Patents
Klaus Koch holds 1 patent for his invention titled "Stable dosage form of phenylalanine derivatives." This patent addresses the need for improved and stable pharmaceutical formulations, which are crucial for effective treatment options in oncology.
Career Highlights
Klaus Koch is associated with Wilex AG, a company dedicated to developing innovative therapies for cancer treatment. His expertise in pharmaceutical formulations has positioned him as a key player in the industry.
Collaborations
Throughout his career, Klaus has collaborated with notable colleagues such as Wolfgang Schmalix and Markus Bürgle. These partnerships have contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Klaus Koch's innovative work in pharmaceutical formulations exemplifies the importance of research in developing effective cancer treatments. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile